During the last session, Cogent Biosciences Inc (NASDAQ:COGT)’s traded shares were 0.83 million, with the beta value of the company hitting 1.73. At the end of the trading day, the stock’s price was $8.15, reflecting an intraday loss of -2.28% or -$0.19. The 52-week high for the COGT share is $12.61, that puts it down -54.72 from that peak though still a striking 47.48% gain since the share price plummeted to a 52-week low of $4.28. The company’s market capitalization is $900.26M, and the average intraday trading volume over the past 10 days was 2.29 million shares, and the average trade volume was 1.33 million shares over the past three months.
Cogent Biosciences Inc (COGT) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.55. COGT has a Sell rating from 0 analyst(s) out of 4 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 4 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.58.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Cogent Biosciences Inc (NASDAQ:COGT) trade information
Cogent Biosciences Inc (COGT) registered a -2.28% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -2.28% in intraday trading to $8.15, hitting a weekly high. The stock’s 5-day price performance is -8.32%, and it has moved by -21.63% in 30 days. Based on these gigs, the overall price performance for the year is 83.97%. The short interest in Cogent Biosciences Inc (NASDAQ:COGT) is 8.42 million shares and it means that shorts have 5.91 day(s) to cover.
The consensus price target of analysts on Wall Street is $16, which implies an increase of 49.06% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $15 and $17 respectively. As a result, COGT is trading at a discount of -108.59% off the target high and -84.05% off the low.
Cogent Biosciences Inc (COGT) estimates and forecasts
Statistics show that Cogent Biosciences Inc has underperformed its competitors in share price, compared to the industry in which it operates. Cogent Biosciences Inc (COGT) shares have gone down -3.26% during the last six months, with a year-to-date growth rate less than the industry average at 0.00% against 17.10.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 15.33%. While earnings are projected to return -0.41% in 2024.
COGT Dividends
Cogent Biosciences Inc is due to release its next quarterly earnings in January. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
The next largest institutional holding, with 9.74 million shares, is of COMMODORE CAPITAL LP’s that is approximately 9.8126% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $82.09 million.
Also, the Mutual Funds coming in first place with the largest holdings of Cogent Biosciences Inc (COGT) shares are Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF . Data provided on Sep 30, 2024 indicates that Vanguard Total Stock Market Index Fund owns about 3.09 shares. This amounts to just over 2.80 percent of the company’s overall shares, with a $25.17 million market value. The same data shows that the other fund manager holds slightly less at 2.4, or about 2.17% of the stock, which is worth about $19.56 million.
